A diverse portfolio of stocks will always have winners and losers. Of course, in an ideal world, all your stocks ...

Leaders of the Awami National Party (ANP) on Sunday reaffirmed their commitment to peace, democracy and the protection of ...

PLX READ THE FULL PLX RESEARCH REPORT Protalix BioTherapeutics, Inc. (NYSE:PLX) announced a collaboration with the Germany-based Secarna Pharmaceuticals to develop novel antisense oligonucleotide (ASO ...

As part of the PDAOAI initiative, Oncotelic has curated a comprehensive TGF-β literature corpus comprising more than 125,000 PubMed abstracts, representing the near-totality of scientific knowledge ...

On the 13th anniversary of Shaheed Bashir Ahmed Bilour's martyrdom, Awami National Party (ANP) Central President Senator Aimal Wali Khan paid tribute to the late leader, describing him as a living ...

CAMP4 Therapeutics is pioneering the development of antisense oligonucleotides (ASOs) that target regulatory RNAs (regRNAs). These molecules play a crucial role in gene expression and can influence ...

Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare ...

CAMP4 signs ASO collaboration with GSK, securing $17.5 million upfront as analysts reaffirm Outperform and highlight 2026 ...

In a deal announced Thursday, CAMP4 said it will receive $17.5 million upfront from GSK and will be eligible for development and commercial milestone payments as well as tiered royalties on ...

CAMP4 will apply its RAP Platform® to generate antisense oligonucleotide candidates, while GSK will lead development and ...

Awami National Party (ANP) Khyber-Pakhtunkhwa president Mian Iftikhar Hussain has alleged that terrorism has been turned into ...

Cambridge, USA-based CAMP4 Therapeutics has entered into a strategic research, collaboration and license agreement with UK ...